Purple Mark Pharmaceuticals LLP
About Purple Mark Pharmaceuticals LLP
Data last updated:
Purple Mark Pharmaceuticals LLP is a limited liability partnership (LLP) based in Barwaha, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 15 April 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Gwalior, under LLPIN AAW-7273. Its GSTIN is 23ABAFP2862N1Z2 (Madhya Pradesh).
The LLP has a total obligation of contribution of ₹50,000. It is led by designated partners Ravi Mewade and Ritesh Mewade.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Survey No. 126 Patwari Halka No 18 Block Gram Sirlay Teh. Barwaha, Madhya Pradesh, India – 451115.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSurvey No. 126 Patwari Halka No 18 Block Gram Sirlay Teh. Barwaha, Madhya Pradesh, India – 451115
- IndustryChemicals, Manufacturing, Chemicals And Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Purple Mark Pharmaceuticals LLP FY 2024 filings available
Financial Statement Summary of Purple Mark Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• |
| Assets and Liabilities | |||
| Partners' Contribution | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Purple Mark Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Purple Mark Pharmaceuticals are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Purple Mark Pharmaceuticals LLP
Purple Mark Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Mewade | Designated Partner | 15 Apr 2021 | 5 Years 5 Months | Current |
| Ritesh Mewade | Designated Partner | 15 Apr 2021 | 5 Years 5 Months | Current |
Charges & Borrowings of Purple Mark Pharmaceuticals LLP
Purple Mark Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Purple Mark Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Purple Mark Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Purple Mark Pharmaceuticals LLP
Purple Mark Pharmaceuticals LLP has 2 designated partner changes on record since 2021: 2 appointments. The latest: Ravi Mewade was appointed as Designated Partner on 15 Apr 2021.
Credit Ratings, Litigation & Regulatory Alerts for Purple Mark Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Purple Mark Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Purple Mark Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Purple Mark Pharmaceuticals LLP
Purple Mark Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23ABAFP2862N1Z2 | Madhya Pradesh | Active | 10 May 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Purple Mark Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Purple Mark Pharmaceuticals LLP
Purple Mark Pharmaceuticals is an active limited liability partnership based in Barwaha, Madhya Pradesh, India. The LLP works in manufacturing, within the chemicals industry. It was incorporated on 15 April 2021 (5+ years old) and is registered under LLPIN AAW-7273.
Purple Mark Pharmaceuticals has 2 current designated partners:
- Ravi Mewade - Designated Partner
- Ritesh Mewade - Designated Partner
The GSTIN of Purple Mark Pharmaceuticals is 23ABAFP2862N1Z2, registered in Madhya Pradesh.
The LLPIN (Limited Liability Partnership Identification Number) of Purple Mark Pharmaceuticals is AAW-7273. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Purple Mark Pharmaceuticals was incorporated on 15 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
Ravi Mewade was appointed as Designated Partner on 15 Apr 2021. Ritesh Mewade was appointed as Designated Partner on 15 Apr 2021.
The registered office of Purple Mark Pharmaceuticals is at Survey No. 126 Patwari Halka No 18 Block Gram Sirlay Teh. Barwaha, Madhya Pradesh, India – 451115.
The total obligation of contribution is ₹50,000.
Purple Mark Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Purple Mark Pharmaceuticals can be reached at its registered office: Survey No. 126 Patwari Halka No 18 Block Gram Sirlay Teh. Barwaha, Madhya Pradesh, India – 451115.